<p>Ransom Advisory Ltd 在最近向证券交易委员会（SEC）提交的文件中表示，在第三季度其对礼来公司的持股增加了 112.9%。该公司在季度内额外购买了 1,300 股后，持有该公司 2,451 股股票。礼来公司约占 Ransom Advisory Ltd 持股的 0.8%，使其成为该公司第 29 大持股。根据最近的 SEC 文件，Ransom Advisory Ltd 在礼来公司的持股价值为 1,870,000 美元。</p>
<p>获取 <strong>礼来公司</strong> 的提醒：</p>
<ul>
<li>3 家医疗巨头刚刚提高了股息——看看谁支付得最多</li>
</ul>
<p>其他一些大型投资者最近也买卖了 LLY 的股票。财富保护顾问公司在第一季度购买了价值约 27,000 美元的礼来公司新股份。住友三井金融集团在第二季度收购了价值约 27,000 美元的礼来公司新股份。进化财富管理公司在第二季度收购了价值约 29,000 美元的礼来公司新股份。Steph &amp; Co.在第三季度将其在礼来公司的股份提高了 290.0%。Steph &amp; Co.现在持有 39 股该公司股票，价值 30,000 美元，此前在上个季度额外购买了 29 股。最后，金融重力公司在第二季度收购了价值约 31,000 美元的礼来公司新股份。机构投资者和对冲基金持有该公司 82.53% 的股票。</p>
<h2>华尔街分析师观点</h2>
<p>LLY 最近成为多份研究报告的主题。桑福德·C·伯恩斯坦在 11 月 24 日的报告中将礼来公司的目标价格从 1,100.00 美元提高至 1,300.00 美元，并给予该公司 “跑赢大盘” 的评级。瑞银集团在 11 月 7 日的研究报告中将礼来公司的目标价格从 895.00 美元提高至 1,080.00 美元，并给予该公司 “买入” 评级。汇丰全球研究在 8 月 27 日的研究报告中将礼来公司的评级从 “适度卖出” 上调至 “持有”。韦斯评级在周一的报告中重申了对礼来公司的 “买入（b-）” 评级。最后，大和美国在周二的报告中将礼来公司的评级从 “持有” 上调至 “强烈买入”。四位分析师给予该股票 “强烈买入” 评级，十八位给予 “买入” 评级，四位给予 “持有” 评级。根据 MarketBeat.com 的数据，该股票的平均评级为 “买入”，平均目标价格为 1,141.73 美元。</p>
<ul>
<li>辉瑞加大对减肥药的投资</li>
</ul>
<p><strong>查看我们最新的 LLY 股票报告</strong></p>
<h2>礼来公司的价格表现</h2>
<p>NYSE LLY 的股票在周四开盘价为 1,042.06 美元。该公司的债务与股本比率为 1.71，速动比率为 1.24，流动比率为 1.55。礼来公司的股价一年低点为 623.78 美元，一年高点为 1,111.99 美元。该公司的市值为 985.14 亿美元，市盈率为 50.98，市盈增长比率为 1.32，贝塔系数为 0.37。该公司的 50 日移动平均线为 951.95 美元，200 日移动平均线为 826.51 美元。</p>
<ul>
<li>黄金交叉警报：3 只具有重大上涨潜力的股票</li>
</ul>
<p>礼来公司（NYSE:LLY - 获取免费报告）最近在 10 月 30 日宣布了季度财报。该公司报告季度每股收益为 7.02 美元，超出市场共识预期的 6.42 美元，超出幅度为 0.60 美元。该公司在季度内的收入为 176 亿美元，而分析师预期为 160.9 亿美元。礼来公司的净利润率为 30.99%，股本回报率为 109.52%。与去年同期相比，该公司的季度收入增长了 53.9%。去年同期，该公司的每股收益为 1.18 美元。礼来公司已将其 2025 财年的指导目标设定为 23.000-23.700 每股收益。分析师预测礼来公司本财年的每股收益为 23.48 美元。</p>
<h2>礼来公司增加股息</h2>
<p>该公司最近宣布了一项季度股息，将于 3 月 10 日支付。记录在案的股东将在 2 月 13 日获得每股 1.73 美元的股息。这是礼来公司之前每季度 1.50 美元股息的积极变化。该股息的除息日为 2 月 13 日。这代表着每年 6.92 美元的股息和 0.7% 的股息收益率。礼来公司的股息支付比率目前为 29.35%。</p>
<h2>关于礼来公司</h2>
<p>（免费报告）</p>
<p>礼来公司在全球范围内发现、开发和销售人用药物。该公司提供 Basaglar、Humalog、Humalog Mix 75/25、Humalog U-100、Humalog U-200、Humalog Mix 50/50、胰岛素利普罗、胰岛素利普罗原料、胰岛素利普罗混合 75/25、Humulin、Humulin 70/30、Humulin N、Humulin R 和 Humulin U-500 用于糖尿病；Jardiance、Mounjaro 和 Trulicity 用于 2 型糖尿病；以及 Zepbound 用于肥胖。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票超过礼来公司</li>
<li>如何利用高贝塔股票最大化投资收益</li>
<li>在上涨 35% 后，分析师关注铜业巨头 Freeport 的更多上涨潜力</li>
<li>2 只上升的 CRM 平台股票在 2025 年可能会大幅上涨</li>
<li>为什么 SpaceX 的 IPO 可能成为 GOOGL 股票的主要催化剂</li>
<li>股票拆分，真的会影响投资者吗？</li>
<li>Upwork 能否维持其复苏？看涨和看跌的理由</li>
</ul>
<p><strong>想看看其他对冲基金持有的 LLY 吗？</strong> 访问 HoldingsChannel.com 获取礼来公司（NYSE:LLY - 免费报告）的最新 13F 文件和内部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在礼来公司吗？</h2>
<p>在考虑礼来公司之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而礼来公司并不在名单上。</p>
<p>尽管礼来公司目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

礼来

<p>Ransom Advisory Ltd 在第三季度将其在礼来的持股增加了 112.9%，目前拥有 2,451 股，价值 1,870,000 美元。分析师对礼来给予了强烈买入评级，平均目标价为 1,141.73 美元。该股票开盘价为 1,042.06 美元，市值为 985.14 亿美元。礼来报告第三季度每股收益为 7.02 美元，超出预期，并将每股股息提高至 1.73 美元</p>

<p>Ransom Advisory Ltd increased its holdings in Eli Lilly and Company (NYSE:LLY - Free Report) by 112.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,451 shares of the company's stock after acquiring an additional 1,300 shares during the quarter. Eli Lilly and Company makes up about 0.8% of Ransom Advisory Ltd's holdings, making the stock its 29th biggest position. Ransom Advisory Ltd's holdings in Eli Lilly and Company were worth $1,870,000 as of its most recent SEC filing.</p>
<div class="lb-trans"><p>Ransom Advisory Ltd 在最近向证券交易委员会（SEC）提交的文件中表示，在第三季度其对礼来公司的持股增加了 112.9%。该公司在季度内额外购买了 1,300 股后，持有该公司 2,451 股股票。礼来公司约占 Ransom Advisory Ltd 持股的 0.8%，使其成为该公司第 29 大持股。根据最近的 SEC 文件，Ransom Advisory Ltd 在礼来公司的持股价值为 1,870,000 美元。</p>
</div><p>Get <strong>Eli Lilly and Company</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>礼来公司</strong> 的提醒：</p>
</div><ul>
<li>3 Healthcare Giants Just Raised Dividends—Here’s Who Pays the Most</li>
</ul>
<div class="lb-trans"><ul>
<li>3 家医疗巨头刚刚提高了股息——看看谁支付得最多</li>
</ul>
</div><p>A number of other large investors have also recently bought and sold shares of LLY. Wealth Preservation Advisors LLC purchased a new stake in shares of Eli Lilly and Company in the first quarter valued at about $27,000. Sumitomo Mitsui Financial Group Inc. acquired a new position in Eli Lilly and Company in the 2nd quarter valued at about $27,000. Evolution Wealth Management Inc. acquired a new position in Eli Lilly and Company in the 2nd quarter valued at about $29,000. Steph &amp; Co. raised its stake in Eli Lilly and Company by 290.0% during the 3rd quarter. Steph &amp; Co. now owns 39 shares of the company's stock valued at $30,000 after acquiring an additional 29 shares during the last quarter. Finally, Financial Gravity Companies Inc. acquired a new stake in Eli Lilly and Company during the 2nd quarter worth approximately $31,000. Institutional investors and hedge funds own 82.53% of the company's stock.</p>
<div class="lb-trans"><p>其他一些大型投资者最近也买卖了 LLY 的股票。财富保护顾问公司在第一季度购买了价值约 27,000 美元的礼来公司新股份。住友三井金融集团在第二季度收购了价值约 27,000 美元的礼来公司新股份。进化财富管理公司在第二季度收购了价值约 29,000 美元的礼来公司新股份。Steph &amp; Co.在第三季度将其在礼来公司的股份提高了 290.0%。Steph &amp; Co.现在持有 39 股该公司股票，价值 30,000 美元，此前在上个季度额外购买了 29 股。最后，金融重力公司在第二季度收购了价值约 31,000 美元的礼来公司新股份。机构投资者和对冲基金持有该公司 82.53% 的股票。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><p>LLY has been the topic of a number of recent research reports. Sanford C. Bernstein boosted their target price on Eli Lilly and Company from $1,100.00 to $1,300.00 and gave the company an &#34;outperform&#34; rating in a report on Monday, November 24th. UBS Group boosted their price objective on shares of Eli Lilly and Company from $895.00 to $1,080.00 and gave the company a &#34;buy&#34; rating in a research note on Friday, November 7th. Hsbc Global Res upgraded shares of Eli Lilly and Company from a &#34;moderate sell&#34; rating to a &#34;hold&#34; rating in a research note on Wednesday, August 27th. Weiss Ratings reaffirmed a &#34;buy (b-)&#34; rating on shares of Eli Lilly and Company in a report on Monday. Finally, Daiwa America raised shares of Eli Lilly and Company from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a report on Tuesday. Four analysts have rated the stock with a Strong Buy rating, eighteen have assigned a Buy rating and four have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of &#34;Buy&#34; and an average target price of $1,141.73.</p>
<div class="lb-trans"><p>LLY 最近成为多份研究报告的主题。桑福德·C·伯恩斯坦在 11 月 24 日的报告中将礼来公司的目标价格从 1,100.00 美元提高至 1,300.00 美元，并给予该公司 “跑赢大盘” 的评级。瑞银集团在 11 月 7 日的研究报告中将礼来公司的目标价格从 895.00 美元提高至 1,080.00 美元，并给予该公司 “买入” 评级。汇丰全球研究在 8 月 27 日的研究报告中将礼来公司的评级从 “适度卖出” 上调至 “持有”。韦斯评级在周一的报告中重申了对礼来公司的 “买入（b-）” 评级。最后，大和美国在周二的报告中将礼来公司的评级从 “持有” 上调至 “强烈买入”。四位分析师给予该股票 “强烈买入” 评级，十八位给予 “买入” 评级，四位给予 “持有” 评级。根据 MarketBeat.com 的数据，该股票的平均评级为 “买入”，平均目标价格为 1,141.73 美元。</p>
</div><ul>
<li>Pfizer Adds to Its Big Bet on Weight Loss Drugs</li>
</ul>
<div class="lb-trans"><ul>
<li>辉瑞加大对减肥药的投资</li>
</ul>
</div><p><strong>View Our Latest Stock Report on LLY</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的 LLY 股票报告</strong></p>
</div><h2>Eli Lilly and Company Price Performance</h2>
<div class="lb-trans"><h2>礼来公司的价格表现</h2>
</div><p>Shares of NYSE LLY opened at $1,042.06 on Thursday. The company has a debt-to-equity ratio of 1.71, a quick ratio of 1.24 and a current ratio of 1.55. Eli Lilly and Company has a one year low of $623.78 and a one year high of $1,111.99. The firm has a market capitalization of $985.14 billion, a P/E ratio of 50.98, a PEG ratio of 1.32 and a beta of 0.37. The company's fifty day moving average is $951.95 and its two-hundred day moving average is $826.51.</p>
<div class="lb-trans"><p>NYSE LLY 的股票在周四开盘价为 1,042.06 美元。该公司的债务与股本比率为 1.71，速动比率为 1.24，流动比率为 1.55。礼来公司的股价一年低点为 623.78 美元，一年高点为 1,111.99 美元。该公司的市值为 985.14 亿美元，市盈率为 50.98，市盈增长比率为 1.32，贝塔系数为 0.37。该公司的 50 日移动平均线为 951.95 美元，200 日移动平均线为 826.51 美元。</p>
</div><ul>
<li>Golden Cross Alert: 3 Stocks With Major Upside Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>黄金交叉警报：3 只具有重大上涨潜力的股票</li>
</ul>
</div><p>Eli Lilly and Company (NYSE:LLY - Get Free Report) last announced its quarterly earnings data on Thursday, October 30th. The company reported $7.02 EPS for the quarter, beating the consensus estimate of $6.42 by $0.60. The firm had revenue of $17.60 billion during the quarter, compared to analysts' expectations of $16.09 billion. Eli Lilly and Company had a net margin of 30.99% and a return on equity of 109.52%. The business's revenue for the quarter was up 53.9% compared to the same quarter last year. During the same quarter last year, the business earned $1.18 earnings per share. Eli Lilly and Company has set its FY 2025 guidance at 23.000-23.700 EPS. Analysts forecast that Eli Lilly and Company will post 23.48 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>礼来公司（NYSE:LLY - 获取免费报告）最近在 10 月 30 日宣布了季度财报。该公司报告季度每股收益为 7.02 美元，超出市场共识预期的 6.42 美元，超出幅度为 0.60 美元。该公司在季度内的收入为 176 亿美元，而分析师预期为 160.9 亿美元。礼来公司的净利润率为 30.99%，股本回报率为 109.52%。与去年同期相比，该公司的季度收入增长了 53.9%。去年同期，该公司的每股收益为 1.18 美元。礼来公司已将其 2025 财年的指导目标设定为 23.000-23.700 每股收益。分析师预测礼来公司本财年的每股收益为 23.48 美元。</p>
</div><h2>Eli Lilly and Company Increases Dividend</h2>
<div class="lb-trans"><h2>礼来公司增加股息</h2>
</div><p>The company also recently declared a quarterly dividend, which will be paid on Tuesday, March 10th. Stockholders of record on Friday, February 13th will be paid a dividend of $1.73 per share. This is a positive change from Eli Lilly and Company's previous quarterly dividend of $1.50. The ex-dividend date of this dividend is Friday, February 13th. This represents a $6.92 annualized dividend and a dividend yield of 0.7%. Eli Lilly and Company's dividend payout ratio is presently 29.35%.</p>
<div class="lb-trans"><p>该公司最近宣布了一项季度股息，将于 3 月 10 日支付。记录在案的股东将在 2 月 13 日获得每股 1.73 美元的股息。这是礼来公司之前每季度 1.50 美元股息的积极变化。该股息的除息日为 2 月 13 日。这代表着每年 6.92 美元的股息和 0.7% 的股息收益率。礼来公司的股息支付比率目前为 29.35%。</p>
</div><h2>About Eli Lilly and Company</h2>
<div class="lb-trans"><h2>关于礼来公司</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.</p>
<div class="lb-trans"><p>礼来公司在全球范围内发现、开发和销售人用药物。该公司提供 Basaglar、Humalog、Humalog Mix 75/25、Humalog U-100、Humalog U-200、Humalog Mix 50/50、胰岛素利普罗、胰岛素利普罗原料、胰岛素利普罗混合 75/25、Humulin、Humulin 70/30、Humulin N、Humulin R 和 Humulin U-500 用于糖尿病；Jardiance、Mounjaro 和 Trulicity 用于 2 型糖尿病；以及 Zepbound 用于肥胖。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Eli Lilly and Company</li>
<li>How to Use High Beta Stocks to Maximize Your Investing Profits</li>
<li>Post 35% Surge, Analysts Eye More Upside in Copper Giant Freeport</li>
<li>2 Rising CRM Platform Stocks That Can Surge Higher in 2025</li>
<li>Why a SpaceX IPO Could Be a Major Catalyst for GOOGL Stock</li>
<li>Stock Splits, Do They Really Impact Investors?</li>
<li>Can Upwork Maintain Its Comeback? Reasons to Be Bullish and Bearish</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票超过礼来公司</li>
<li>如何利用高贝塔股票最大化投资收益</li>
<li>在上涨 35% 后，分析师关注铜业巨头 Freeport 的更多上涨潜力</li>
<li>2 只上升的 CRM 平台股票在 2025 年可能会大幅上涨</li>
<li>为什么 SpaceX 的 IPO 可能成为 GOOGL 股票的主要催化剂</li>
<li>股票拆分，真的会影响投资者吗？</li>
<li>Upwork 能否维持其复苏？看涨和看跌的理由</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding LLY?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Eli Lilly and Company (NYSE:LLY - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对冲基金持有的 LLY 吗？</strong> 访问 HoldingsChannel.com 获取礼来公司（NYSE:LLY - 免费报告）的最新 13F 文件和内部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUxMWQ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=LLY"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。请将有关此故事的任何问题或评论发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Eli Lilly and Company Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在礼来公司吗？</h2>
</div><p>Before you consider Eli Lilly and Company, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑礼来公司之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而礼来公司并不在名单上。</p>
</div><p>While Eli Lilly and Company currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>尽管礼来公司目前在分析师中获得了买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Ransom Advisory Ltd 增加了在礼来公司（Eli Lilly）的股票持仓 $LLY